ANGIOTENSIN II REGULATION OF EXTRACELLULAR MATRIX PROTEINS: LYSYL OXIDASE AND OSTEOPONTIN Public
Remus, Ebony Renee Washington (2012)
Abstract
Abstract
ANGIOTENSIN II REGULATION OF EXTRACELLULAR MATRIX
PROTEINS:
LYSYL OXIDASE AND OSTEOPONTIN
By
Ebony Washington Remus
The renin angiotensin system has been implicated in the
pathogenesis of cardiovascular disease through its primary effector
molecule Angiotensin II (AngII). Ang II is multifunctional hormone
that acts as a potent vasoconstrictor, mediating its action on
cells within the vasculature primarily through the angiotensin I
receptor. Vascular smooth muscle cells (VSMCs) are a prominent cell
type within the vasculature on which Ang II exerts its effects. Ang
II bound to its receptor initiates intracellular signaling events
that lead to hypertrophy, hyperplasia, migration, adhesion and an
increased oxidative state of vascular smooth muscle cells. These
changes are mediated in part changes to the extracellular matrix
environment, leading to the progression of atherosclerosis and
abdominal aortic aneurysms. Within this thesis, we will explore Ang
II regulation on two important extracellular matrix components
implicated in vessel stability: lysyl oxidase and osteopontin. The
lysyl oxidase family of extracellular matrix enzymes crosslink
collagen and elastin, thereby enhancing vessel wall stability.
Osteopontin is an extracellular matrix protein that facilitates
adhesion, migration and inflammation in vascular smooth muscle
cells. While lysyl oxidase contributes to the stability of the
vessel wall, osteopontin represents an extracellular matrix protein
that decreases vessel integrity. This thesis aims to understand the
regulation of these extracellular matrix proteins using both in
vivo disease models and primary cell culture. The results from
these experiments support the notion that lysyl oxidase stabilizes
vessel structure in a mouse model of abdominal aortic aneurysms;
however Ang II does not directly regulate its activity or
expression in vascular smooth muscle cells. Conversely, Ang II does
increase osteopontin expression in a mouse model of hypertension
that precedes atherosclerosis formation. Furthermore, by uncovering
a previously unreported translation dependent induction of
osteopontin protein expression were able to identify a novel
mechanism for inhibiting Ang II induced osteopontin expression
using microRNAs.
Table of Contents
Table of Contents
Figure legend
......................................................................................................
x
Abbreviations
...................................................................................................
xiv
Chapter 1: Background
......................................................................................
1
Angiotensin II and Cardiovascular Disease
................................................................2
Hypertension
.........................................................................................................................................
4
Atherosclerosis
.....................................................................................................................................
5
Abdominal Aortic Aneurysms
.............................................................................................................
8
Angiotensin II
................................................................................................................
11
Renin Angiotensin System
...............................................................................................................
11
In vitro angiotensin II signaling
.........................................................................................................
12
Migration and adhesion of vascular smooth muscle cells
............................................................
15
Extracellular Matrix
......................................................................................................
19
Lysyl Oxidase and Lysyl Oxidase Like Isoenzymes
.....................................................................
19
Osteopontin
.........................................................................................................................................
25
Scope of Dissertation
..................................................................................................
27
Chapter 2: The role of Angiotensin II on Lysyl Oxidase Family
Members in
the regulation of Abdominal Aortic Aneurysms and in cultured
Vascular
Smooth Muscle Cells.
......................................................................................
29
Part 1. The Role of Lysyl Oxidase Family Members in the
Stabilization of
Abdominal Aortic Aneurysms
....................................................................................
30
Introduction
.........................................................................................................................................
32
Methods
...............................................................................................................................................
34
Animals
...........................................................................................................................................
34
Immunostaining
..............................................................................................................................
35
Quantitative Real Time - PCR
.....................................................................................................
35
Western Blot
...................................................................................................................................
38
Additional Reagents
......................................................................................................................
38
Statistical Analysis
.........................................................................................................................
38
Results
.................................................................................................................................................
39
LOXL3 mRNA expression is significantly upregulated in the aortas of
Ang II treated ApoE-/- mice fed a high fat diet.
..............................................................................................................
39
LOX/LOXL proteins are expressed in the aortic wall
...............................................................
44
LOX/LOXL activity protects against abdominal aortic aneurysm
formation .......................... 46
LOX/LOXL activity protects against Ang II induced atherosclerotic
lesion formation .......... 49
Discussion
...........................................................................................................................................
55
Part II. The Regulation of LOX/LOXL family member expression in
Vascular
Smooth Muscle Cells by Angiotensin II
....................................................................
59
Introduction
.........................................................................................................................................
60
Methods
...............................................................................................................................................
62
viii
Cell culture
......................................................................................................................................
62
Quantitative Real
Time-PCR........................................................................................................
63
Western blotting
.............................................................................................................................
64
LOX/LOXL Activity Assay
.............................................................................................................
64
Results
.................................................................................................................................................
66
Ang II has variable effects of LOX/LOXL family members at the mRNA
level in VSMCs .. 66
Ang II has no effect of LOX/LOXL protein expression in cultured
VSMCs ........................... 71
Ang II does not change LOX/LOXL activity
...............................................................................
73
Discussion
...........................................................................................................................................
75
Chapter 3: The regulation of miRNAs by Angiotensin II in VSMCs
.............. 81
Introduction
.........................................................................................................................................
83
Methods
...............................................................................................................................................
88
Cell culture
......................................................................................................................................
89
microRNA Array and Analysis
.....................................................................................................
89
miRNA Extraction and qRT-PCR Validation
..............................................................................
91
Overexpressing and Antagonizing mir26b
.................................................................................
92
Flow Cytometry
..............................................................................................................................
93
Protein Isolation
.............................................................................................................................
93
Western blotting
.............................................................................................................................
93
Statistical Analysis
.........................................................................................................................
94
Results
.................................................................................................................................................
96
Ang II modulates several miRNAs in VSMCs
...........................................................................
96
Several miRNAs are predicted to target LOXL1 and LOXL2
.................................................. 99
Ang II has differential effects on the expression of miRNA
processing enzymes drosha
and dicer
.......................................................................................................................................
103
miRNAs and potential mRNA targets
.......................................................................................
106
Discussion
.........................................................................................................................................
109
Chapter 4. mir181a Protects Against Ang II-Induced
Osteopontin
Expression in Vascular Smooth Muscle Cells
............................................. 111
Introduction
.......................................................................................................................................
113
Methods
.............................................................................................................................................
115
Animals
.........................................................................................................................................
115
Cell Culture
...................................................................................................................................
115
Quantitative Real Time-Polymerase Chain Reaction
.............................................................
116
Western blotting and ELISA
.......................................................................................................
116
miRNA isolation
...........................................................................................................................
117
mir181a Overexpression
............................................................................................................
117
Adhesion Assay
...........................................................................................................................
118
Statistical Analysis
.......................................................................................................................
118
Results
...............................................................................................................................................
119
Ang II increases OPN protein expression in vivo and in vitro
............................................... 119
Early increases in Ang II-induced OPN expression are
transcriptionally independent ..... 123
Ang II decreases mir181a expression
......................................................................................
125
Overexpression of mir181a inhibits Ang II induced OPN protein
expression ..................... 127
mir181a overexpression inhibits Ang II-mediated VSMC Adhesion
.................................... 130
Discussion
.........................................................................................................................................
135
Chapter 5: Summary and Future
Directions.................................................
142
References
......................................................................................................
152
x
Figure Legend
FIGURE 1. THE STRUCTURE OF AN ARTERY.
..................................................................................
2
FIGURE 2. THE PROGRESSION OF ATHEROSCLEROSIS.
............................................................
5
FIGURE 3. INFILTRATION OF LEUKOCYTES INTO THE VASCULAR WALL.
.............................. 7
FIGURE 4. ANG II INTRACELLULAR SIGNALING EVENTS
............................................................
14
FIGURE 5. ADHESION AND MIGRATION
...........................................................................................
18
FIGURE 6. THE LYSYL OXIDASE FAMILY
........................................................................................
22
FIGURE 7. ACHIEVING VESSEL STABILITY
......................................................................................
24
FIGURE 8. OSTEOPONTIN HAS EXTENSIVE POSTTRANSLATION MODIFICATIONS.
.......... 25
FIGURE 9. ANG II INFUSION LEADS TO INCREASED SYSTOLIC BLOOD
PRESSURES. ...... 41
FIGURE 10. LOX/LOXL FAMILY MEMBER EXPRESSION 7 DAYS AFTER ANG II
INFUSION IN
THE PRESENCE OF A HIGH FAT DIET.
......................................................................................
42
FIGURE 11. LOX/LOXL FAMILY MEMBER PROTEIN EXPRESSION 7 DAYS AFTER
ANG II
INFUSION IN THE PRESENCE OF A HIGH FAT DIET.
.............................................................
43
FIGURE 12. LOCALIZATION OF LOX/LOXL PROTEINS IN AORTIC TISSUE FROM
APOE-/-
MICE AFTER 8 WEEKS.
..................................................................................................................
45
FIGURE 13. EFFECT OF Î'-APN ON AAA INCIDENCE AND
ATHEROSCLEROTIC LESION
AREA IN APOE-/- MICE ON A HIGH FAT DIET WITH ANG II INFUSION.
.............................. 47
FIGURE 14. EFFECT OF Î'-APN ON AAA INCIDENCE AND
ATHEROSCLEROTIC LESION
AREA IN APOE-/- MICE ON A HIGH FAT DIET WITH ANG II INFUSION.
.............................. 48
FIGURE 15. EFFECT OF Î'-APN ON AAA INCIDENCE AND
ATHEROSCLEROTIC LESION
AREA IN C57BL/6 MICE ON A HIGH FAT DIET WITH ANG II.
................................................. 51
FIGURE 16. EFFECT OF Î'-APN ON AAA INCIDENCE AND
ATHEROSCLEROTIC LESION
AREA IN C57BL/6 MICE ON A HIGH FAT DIET WITH ANG II.
................................................. 52
FIGURE 17. EFFECT OF Î'-APN ON AAA INCIDENCE AND
ATHEROSCLEROTIC LESION
AREA IN BALBC MICE ON A HIGH FAT DIET WITH ANG II.
................................................... 53
About this Dissertation
School | |
---|---|
Department | |
Subfield / Discipline | |
Degree | |
Submission | |
Language |
|
Research Field | |
Mot-clé | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
ANGIOTENSIN II REGULATION OF EXTRACELLULAR MATRIX PROTEINS: LYSYL OXIDASE AND OSTEOPONTIN () | 2018-08-28 16:31:00 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|